This medication is taken once daily on an empty stomach, at least 30 minutes before the first food, beverage, or other oral medication of the day
The pivotal RECONNECT Phase 3 trials, two identically designed randomized, double-blind, placebo-controlled studies involving 1,267 women, established the peptide's therapeutic benefit
The calibration curves demonstrated excellent linearity within the range of 0.12.5 g/mL, and the LOD was determined to be 0.024 g/mL
Alternatively, after culture for 24 h, cells were similarly treated with a range of PE concentrations (1, 5, 10, 25, 50, 100, 150, 200 M), with six replicates per sample
Red-emissive carbon dot (RCDs@Ag(+)) nanohybrid as a dual-functional platform for glutathione sensing and antibacterial applications